Document is current
Any future updates will be listed below
-
Authors
Borrmann, Steffen https://orcid.org/0000-0001-9189-4393
Sulyok, Zita https://orcid.org/0009-0007-4311-4509
Müller, Katja https://orcid.org/0000-0001-5100-0981
Fendel, Rolf https://orcid.org/0000-0003-4716-0311
Sulyok, Mihály
Friesen, Johannes
Lalremruata, Albert https://orcid.org/0000-0002-4692-7835
Sandri, Thaisa Lucas
Nguyen, The Trong https://orcid.org/0000-0002-5433-7712
Calle, Carlos Lamsfus https://orcid.org/0000-0002-6766-1765
Knoblich, Annette
Sefried, Stephanie
Ibáñez, Javier https://orcid.org/0000-0001-6215-6332
Lorenz, Freia-Raphaella https://orcid.org/0000-0002-7401-2720
Heimann, Henri Lynn
Weller, David M
Steuder, Regina
Adukpo, Selorme https://orcid.org/0000-0003-3173-996X
Granados Bayon, Patricia
Molnár, Zsófia
Esen, Meral
Metzger, Wolfram
James, Eric R
Ruben, Adam
Abebe, Yonas
Chakravarty, Sumana
Manoj, Anita
KC, Natasha
Murshedkar, Tooba
Hafalla, Julius C R https://orcid.org/0000-0002-5452-9263
Woldearegai, Tamirat Gebru https://orcid.org/0000-0001-9508-1787
O’Rourke, Fiona
Held, Jana
Billingsley, Pete https://orcid.org/0000-0003-1142-4813
Sim, B Kim Lee https://orcid.org/0000-0002-8598-8905
Richie, Thomas L https://orcid.org/0000-0002-2946-5456
Hoffman, Stephen L
Kremsner, Peter G
Matuschewski, Kai https://orcid.org/0000-0001-6147-8591
Mordmüller, Benjamin https://orcid.org/0000-0001-9101-2768
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Infektionsforschung (TTU 03.913)
Deutsches Zentrum für Infektionsforschung (TTU 03.905)
HHS | NIH | National Institute of Allergy and Infectious Diseases
Small Business Innovation Research (5R44AI055229)
Small Business Innovation Research (2R44AI058375)
Deutsche Forschungsgemeinschaft (SFB544)
Deutsche Forschungsgemeinschaft (BO 2494/3-2)
Deutsche Forschungsgemeinschaft (BO 2494/7-1)
Deutscher Akademischer Austauschdienst (57592740)
EC | H2020 | ERA-LEARN | European and Developing Countries Clinical Trials Partnership (101145698)
Angewandte Klinische Forschung (346-0-0)
Max Planck Institute for Infection Biology
- License Information
-
More Information
Article History
Received: 14 January 2025
Revised: 17 July 2025
Accepted: 22 July 2025
First Online: 29 September 2025
Disclosure and competing interests statement
: ERJ, YA, SC, NKC, TM, BKLS, TLR and SLH are all full-time employees of Sanaria Inc., Rockville, MD, the developer and owner of PfSPZ products. PFB, AR and AM were full-time employees of Sanaria Inc. at the time the work was performed. BKLS and SLH have financial interests in Sanaria Inc. and are named inventors of patents related to Purified Plasmodium and Vaccine compositions.
